As the clinical demand for tumor gene testing continues to grow, in-hospital testing has gradually become the mainstream for high-throughput sequencing applications. However, the complexity and stability of the sequencing library preparation process can pose challenges. 01 Manual operation 2017: MGISP-100 developed for hospitals was officially released The automated library preparation equipment had to meet very specific requirements to be deployed in the hospital: the ability to process...

As the application field of MGI's Platform based on DNBSEQ ™ technology becomes more diverse and broader, MGI Platform integrates many excellent companies in the industry with their natural principle advantages, open and shared compatibility, and continuous innovation of technology products, aiming to jointly build an open industry ecology. Recently, MGI and a number of institutions in the Asia-Pacific region reached a cooperation intention to jointly build a high-throughput sequencing p...

On September 9, 2019, DNBSEQ-T7, an ultra-high-throughput gene sequencer independently developed by MGI, was officially released for commercial use. Among them, WeGene is the first batch of customers of DNBSEQ-T7 sequencer. Recently, MGI invited Dr. Gang Chen, the founder and CEO of WeGene, to conduct an interview. Dr. Gang Gang, the founder and CEO of WeGene The data of whole genome sequencing is very valuable， which can better meet the detection of more complex mutations. In the applica...

On December 10th His Excellency Sheikh Abdulla Bin Mohamed Al Hamed, Chairman of the Department of Health -- Abu Dhabi, officially announced the launch of the world 's most comprehensive genome program, in which BGI Group will export its gene sequencing technology for the plan. The innovation plan aims to use large-scale genomic data to establish a pioneering medical system for predictive, preventive and personalized treatment. Under the leadership of Abu Dhabi's Department of Health, the plan ...

In October this year, the "Million Microbiome of Humans Project“(MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14) in Shenzhen. At that time, we interviewed key representatives of the program, including Lars Engstrand, professor at the Center for Microbial Translational Research at the Karolinska Institutet and Liu Ruixin, researcher at the Shanghai National Clinical Research Center for Metabolic Diseases. Recently, MGI officially opened a new R&D a...

High-throughput sequencing technology has developed rapidly in recent years, and has been widely used in non-invasive prenatal screening, tumor-targeted gene mutation detection, hereditary tumor detection, genetic and rare disease detection, pathogenic microorganisms and metagenomic detection, PGD / PGS However, there are many steps in high-throughput sequencing and the procedures are very complicated. From sample pre-processing and library construction to sequencing and report interpretat...